TITLE

GnRH Antagonist Produces Similar Results as GnRH-Agonist

PUB. DATE
December 2010
SOURCE
Fertility Weekly;12/6/2010, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents a study which aims to determine the effectiveness of luteinizing hormone releasing hormone (GnRH) antagonist and luteinizing hormone releasing hormone (GnRH) agonist protocol in polycystic ovary syndrome (PCOS) patients pretreated with oral contraceptive pill (OCP). Participants in the study which involved PCOS patients younger than 35 years old are mentioned. Results showed that the use of GnRH antagonist protocol shows similar results as that of the GnRH agonist protocol.
ACCESSION #
55738016

 

Related Articles

  • Comparison of GnRH agonists and antagonists in the outcome of IVF/ICSI in women with polycystic ovary syndrome. Zeinalzadeh, M.; Norani, N.; Esmaeilzadeh, S.; Yousefniapasha, Y.; Firoozpour, M.; Khafri, S. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p58 

    Introduction: To compare the outcome of using gonadotropin-releasing hormone (GnRH) antagonists versus agonists in women with polycystic ovary syndrome (PCOS) who underwent controlled ovarian hyper stimulation (COH) for assisted reproductive techniques (ART). Materials and Methods: A total of...

  • ART, clinical: GnRH agonist/antagonist.  // Human Reproduction;Jul2007 Supplement 1, Vol. 22, pi120 

    The article presents abstracts on the use of gonadotropin-releasing hormone (GnRH) agonists and antagonists in assisted reproductive technology (ART), including the administration of gonadoliberine analogues (GnRH-a) to patients with Hodgkin lymphoma (HL) during chemotherapy and prevention of...

  • Ovarian stimulation in women with high and low body mass index: GnRH agonist versus GnRH antagonist. Kumbak, Banu; Akbas, Hande; Sahin, Levent; Karlikaya, Guvenc; Karagozoglu, Hale; Kahraman, Semra // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2010, Vol. 20 Issue 3, p314 

    This study evaluated women with a high body mass index (BMI) (>40 kg/m²) and low BMI (<18 kg/m²) undergoing assisted reproduction treatment and determined whether the type of gonadotrophin-releasing hormone (GnRH) analogue used has an impact on cycle parameters and outcome. The study...

  • Pregnancy and Birth After GnRH Agonist Treatment for Induction of Final Oocyte Maturation in a... De Jong, Diederick; Van Hooren, Eric G.; Macklon, Nicholas S.; Mannaerts, Bernadette M.J.L.; Fauser, Bart C.J.M. // Journal of Assisted Reproduction & Genetics;Jan2001, Vol. 18 Issue 1, p30 

    Describes the characteristics of a woman who underwent ovarian stimulation for intracytoplasmic sperm injection cotreated with a GnRH antagonist and a single bolus of GnRH agonist to trigger the final stages of oocyte maturation. Impact of ovum pickup and embryo transfer; Analysis of...

  • Ovarian stimulation in polycystic ovary syndrome patients: the role of body mass index. Orvieto, Raoul; Nahum, Ravit; Meltcer, Simion; Homburg, Roy; Rabinson, Jacob; Anteby, Eyal Y.; Ashkenazi, Jacob // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2009, Vol. 18 Issue 3, p333 

    In an attempt to examine whether body mass index (BMI) may influence IVF outcome in polycystic ovary syndrome (PCOS) patients undergoing ovarian stimulation with either gonadotrophin-releasing hormone (GnRH)-agonist (agonist group) or antagonist (antagonist group), 100 IVF cycles were studied:...

  • Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS. Vrtačnik-Bokal, Eda; Klun, Irma Virant; Verdenik, Ivan // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jan2009, Vol. 18 Issue 1, p21 

    The aim of this study was to determine whether follicular oestradiol and vascular endothelial growth factor (VEGF) concentrations in women with polycystic ovarian syndrome (PCOS) differ according to the use of gonadotrophin-releasing hormone (GnRH) antagonists or GnRH agonists. Furthermore, the...

  • Early Cleavage of Zygote Not Accurate in Predicting Embryo Implantation Potential.  // Fertility Weekly;8/10/2009, p9 

    The article reports on the results of a study led by Wen-Jui Yang in Taiwan to test whether early cleavage was a strong indicator of pregnancy in patients undergoing either a GnRH agonists protocol or antagonist protocol for in vitro fertilization (IVF) and ICSI. The study includes 534 patients...

  • GnRH Combined with Luteal Phase Estradiol Comparable to GnRH.  // Fertility Weekly;11/12/2007, p8 

    The article reports on the results of a study conducted in Brazil that addressed the efficacy of combining luteinizing hormone releasing hormone (GnRH) with luteal phase estradiol for ovarian stimulation. The study inhibited a precocious liberation of the luteinizing hormone (LH) by the...

  • GnRH AGONIST AND ANTAGONIST: HOW TO OPTIMIZE THEIR USE IN OVARIAN STIMULATION. Leondires, M. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2010 Supplement 1, Vol. 21 Issue S1, pS9 

    An abstract of the lecture "GnRH Agonist and Antagonist: How to Optimize Their Use in Ovarian Stimulation" by M. Leondires is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics